Literature DB >> 8383101

Management of ductal carcinoma in situ of the breast.

J V Reynolds1, J P Sweeney, N Nolan, A Korebrits, M J Duffy, E W McDermott, N J O'Higgins.   

Abstract

Ductal carcinoma in situ (DCIS) of the breast is thought to represent a number of biologically different processes, ranging in clinical presentation from a palpable mass to a mammographically-detected abnormality. The optimal management of DCIS is controversial. We reviewed our experience in 40 patients with DCIS, 26 with gross disease and 14 with microscopic disease. Treatment was by total mastectomy (n = 21), complete local excision (n = 16), and local excision followed by radiotherapy (n = 3). At a mean follow-up of 34 months (range 3-120), 35 patients (88%) are disease-free. All patients treated by mastectomy remained disease-free, but 3 patients (16%) treated by breast conservation surgery have had local recurrences. All local recurrences were in the same area as the original lesion, two manifesting the same subtype of DCIS and one an invasive carcinoma. The margins of excision were close to the resection margin in all cases that recurred. All four recurrences were successfully managed by mastectomy. Mastectomy is still the most secure and reliable management for DCIS, but pathologically verified wide local excision may be appropriate.

Entities:  

Mesh:

Year:  1993        PMID: 8383101     DOI: 10.1007/bf02942901

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

Review 1.  Ductal carcinoma in situ (intraductal carcinoma) of the breast.

Authors:  S J Schnitt; W Silen; N L Sadowsky; J L Connolly; J R Harris
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

2.  Breast Cancer Detection Demonstration Project: five-year summary report.

Authors:  L H Baker
Journal:  CA Cancer J Clin       Date:  1982 Jul-Aug       Impact factor: 508.702

3.  Duct carcinoma in situ. Pathology and treatment.

Authors:  M D Lagios
Journal:  Surg Clin North Am       Date:  1990-08       Impact factor: 2.741

4.  Follow-up of two treatment modalities for ductal cancer in situ of the breast.

Authors:  L G Arnesson; S Smeds; G Fagerberg; O Gröntoft
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

5.  Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

Authors:  D Rosner; R N Bedwani; J Vana; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

6.  Conservation surgery and radiation therapy in the treatment of operable breast cancer.

Authors:  E D Montague
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

7.  Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures.

Authors:  M D Lagios; P R Westdahl; F R Margolin; M R Rose
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

8.  Prospective study of non-infiltrating carcinoma of the breast.

Authors:  R Ashikari; A G Huvos; R E Snyder
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

9.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

10.  Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up.

Authors:  J A Sunshine; H S Moseley; W S Fletcher; W W Krippaehne
Journal:  Am J Surg       Date:  1985-07       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.